Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn

10 Jan 2025

Abstract excerpt

Importance: Preventive efforts in pregnancy-related alloimmunization have considerably decreased the prevalence of hemolytic disease of the fetus and newborn (HDFN). International studies are therefore essential to obtain a deeper understanding of the postnatal management and outcomes of HDFN. Taken together with numerous treatment options, large practice variations among centers may exist. Objectives: To assess...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood groups and transfusion
Share to Blood transfusion and management
Share to Neonatal Health and Biochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39792381
DOI: 10.1001/jamanetworkopen.2024.54330

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and NewbornPMID 39792381Read ↗

Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Haemolytic disease of the fetus and newbornSemantic proximity Read ↗

Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping.Semantic proximity Read ↗

Treatment Options for the Fetus With Alloimmune Hemolytic DiseaseSemantic proximity Read ↗

Haemolytic disease of the newborn: Table 1Semantic proximity Read ↗

Intravenous Immunoglobulin (IVIG) as a Replacement for Anti-D Prophylaxis: A Systematic Review and Translational Analysis on the Future of Fetal Rhesus Alloimmunization PreventionSemantic proximity Read ↗

Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 yearsSemantic proximity Read ↗

Recommendations for Pregnancy in Rare Inherited AnemiasSemantic proximity Read ↗

AFOG (African Federation of Obstetricians and Gynecologists) Comprehensive Guideline: Prevention and Management of Red Blood Cell Alloimmunization in PregnancySemantic proximity Read ↗

Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: Rare specificities.Semantic proximity Read ↗

Navigating the challenges of Bombay phenotype (Oh ) and twin pregnancy; a case report and literature review.Semantic proximity Read ↗

Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.